Explores cannabinoid conversion pathways, suggesting scalable production methods for therapeutic use.
In this study, a reaction pathway for converting the psychoactive compound Δ 9 -THC into the nonpsychoactive cannabidiol (CBD) was proposed. Related cannabinoids, including Δ 8 -THC and cannabinol (CBN), were also examined. The transformation proceeds via two key steps: (i) hydrogen elimination and cyclic ether ring cleavage, and (ii) hydrolysis to form hydroxyl groups, facilitated by boron trichloride (BCl 3 ) as a Lewis acid and 2,6-di- tert -butyl-4-methylpyridine as a selective base. Energy calculations indicate that TS 4–5 is the rate-determining transition state for Δ 9 -THC, Δ 8 -THC, and CBN, with corresponding activation free energies of 49.4, 50.3, and 54.1 kcal mol –1, respectively. The overall reaction is highly exergonic (Δ G rxn = −33.9 to −32.9 kcal mol –1 ), indicating spontaneous conversion under mild conditions. These results provide a foundation for developing efficient and scalable production of nonpsychoactive cannabinoids, supporting the development of safe and commercially viable therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Kongkaew et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: